Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
Intest Res
.
2021 Jan;19(1):115-118.
doi: 10.5217/ir.2020.00030.
Epub 2020 Jun 11.
Authors
Hiromichi Shimizu
1
,
Toshimitsu Fujii
1
,
Shuji Hibiya
1
,
Maiko Motobayashi
2
,
Kohei Suzuki
3
,
Kento Takenaka
2
,
Eiko Saito
1
,
Masakazu Nagahori
1
,
Kazuo Ohtsuka
2
,
Mamoru Watanabe
4
Affiliations
1
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
2
Department of Endoscopy, Tokyo Medical and Dental University, Tokyo, Japan.
3
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
4
Institute of Advanced Study, Tokyo Medical and Dental University, Tokyo, Japan.
PMID:
32516866
PMCID:
PMC7873398
DOI:
10.5217/ir.2020.00030
No abstract available